Suppr超能文献

对一种微小生物的研究也能造福世界:迷人的细胞黏菌

Research on a Minor Organism can also be Benefit the World: The Fascinating Cellular Slime Mold .

作者信息

Kubohara Yuzuru

出版信息

Juntendo Iji Zasshi. 2024 Sep 11;70(5):339-347. doi: 10.14789/jmj.JMJ24-0021-R. eCollection 2024.

Abstract

In 1985, when I entered the Graduate School of Science at Kyoto University, I began my research on cellular slime molds, a group of soil microorganisms. The cellular slime mold is studied globally as a model organism for cell and developmental biology. I was conducting basic biological research into cell differentiation and migration using , and during this process, our research group made a discovery with potential implications for drug development. Specifically, we found that a chlorinated polyketide named differentiation-inducing factor 1 (DIF-1), derived from , exhibits antitumor activity. Based on this discovery, I began elucidating the mechanism of the antitumor action of DIF-1 and developing anticancer drugs using DIF-1 as a lead compound. During this period, in 1991, I obtained my Ph.D. in research related to cell differentiation, and subsequently served as a Japan Society for the Promotion of Science (JSPS) Special Research Fellow before joining the Institute for Molecular and Cellular Regulation (IMCR) at Gunma University in 1993. I then joined the Graduate School of Health and Sports Sciences at Juntendo University in 2015, where I have been until 2024. Throughout this period, I continued my research on DIF-1 and discovered that DIF-1 and its derivatives possess various biological activities ─ such as anti-diabetic, immunoregulatory, anti-bacterial, and anti-malarial activities ─ that could be applicable in drug development. In this review, I aim to present a segment of both our fundamental and applied research on and DIF-1.

摘要

1985年,我进入京都大学理学研究生院,开始了对细胞黏菌(一类土壤微生物)的研究。细胞黏菌作为细胞和发育生物学的模式生物,在全球范围内得到研究。我当时正在使用……进行关于细胞分化和迁移的基础生物学研究,在此过程中,我们的研究小组有了一项可能对药物开发有影响的发现。具体而言,我们发现一种源自……的名为分化诱导因子1(DIF-1)的氯化聚酮化合物具有抗肿瘤活性。基于这一发现,我开始阐明DIF-1的抗肿瘤作用机制,并以DIF-1作为先导化合物开发抗癌药物。在此期间,1991年,我获得了与细胞分化相关研究的博士学位,随后担任日本学术振兴会(JSPS)特别研究员,1993年加入群马大学分子与细胞调控研究所(IMCR)。2015年,我加入了顺天堂大学健康与体育科学研究生院,一直工作到2024年。在此期间,我继续对DIF-1进行研究,发现DIF-1及其衍生物具有多种生物活性,如抗糖尿病、免疫调节、抗菌和抗疟疾活性,这些活性可应用于药物开发。在这篇综述中,我旨在介绍我们对……和DIF-1的基础研究和应用研究的一部分内容。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f184/11560335/0a953ef467d4/2188-2126-70-5-0339-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验